FindTrial
Sign In

Filgrastim Injection

DRUG2 trials

Sponsors

Andrews Research & Education Foundation, University of Chicago

Conditions

HNSCCHPV-Related Squamous Cell CarcinomaHuman Papilloma VirusOrthopedic DisorderSquamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckStem Cells

Phase 1

Stem Cells After Peripheral Mobilization and Harvest
CompletedNCT03381599
Andrews Research & Education FoundationOrthopedic Disorder, Stem Cells
Start: 2018-03-28End: 2019-09-04Updated: 2020-03-06

Phase 2

De-Escalation Therapy for Human Papillomavirus Negative Disease
CompletedNCT03944915
University of ChicagoHNSCC, HPV-Related Squamous Cell Carcinoma, Human Papilloma Virus +2
Start: 2019-08-26End: 2023-11-01Updated: 2025-05-11

Related Papers

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer
JAMA Oncology2025-03-0616 citations
Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial.
Journal of Clinical Oncology2023-06-0114 citations